Suppr超能文献

多聚谷氨酰胺小脑共济失调相关基因的功能意义。

Functional implications of paralog genes in polyglutamine spinocerebellar ataxias.

机构信息

Instituto de Investigação e Inovação em Saúde (i3S), 4200-135, Porto, Portugal.

Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-135, Porto, Portugal.

出版信息

Hum Genet. 2023 Dec;142(12):1651-1676. doi: 10.1007/s00439-023-02607-4. Epub 2023 Oct 16.

Abstract

Polyglutamine (polyQ) spinocerebellar ataxias (SCAs) comprise a group of autosomal dominant neurodegenerative disorders caused by (CAG/CAA) expansions. The elongated stretches of adjacent glutamines alter the conformation of the native proteins inducing neurotoxicity, and subsequent motor and neurological symptoms. Although the etiology and neuropathology of most polyQ SCAs have been extensively studied, only a limited selection of therapies is available. Previous studies on SCA1 demonstrated that ATXN1L, a human duplicated gene of the disease-associated ATXN1, alleviated neuropathology in mice models. Other SCA-associated genes have paralogs (i.e., copies at different chromosomal locations derived from duplication of the parental gene), but their functional relevance and potential role in disease pathogenesis remain unexplored. Here, we review the protein homology, expression pattern, and molecular functions of paralogs in seven polyQ dominant ataxias-SCA1, SCA2, MJD/SCA3, SCA6, SCA7, SCA17, and DRPLA. Besides ATXN1L, we highlight ATXN2L, ATXN3L, CACNA1B, ATXN7L1, ATXN7L2, TBPL2, and RERE as promising functional candidates to play a role in the neuropathology of the respective SCA, along with the parental gene. Although most of these duplicates lack the (CAG/CAA) region, if functionally redundant, they may compensate for a partial loss-of-function or dysfunction of the wild-type genes in SCAs. We aim to draw attention to the hypothesis that paralogs of disease-associated genes may underlie the complex neuropathology of dominant ataxias and potentiate new therapeutic strategies.

摘要

多聚谷氨酰胺(polyQ)脊髓小脑共济失调(SCAs)是一组由(CAG/CAA)扩展引起的常染色体显性神经退行性疾病。相邻谷氨酰胺的延伸片段改变了天然蛋白质的构象,诱导神经毒性,随后出现运动和神经症状。尽管大多数 polyQ SCA 的病因和神经病理学已经得到了广泛研究,但只有有限的治疗选择。以前对 SCA1 的研究表明,疾病相关 ATXN1 的人类重复基因 ATXN1L,可减轻小鼠模型的神经病理学。其他与 SCA 相关的基因有同源基因(即,来自亲本基因重复的不同染色体位置的副本),但其功能相关性及其在疾病发病机制中的潜在作用仍未得到探索。在这里,我们综述了七个 polyQ 显性共济失调-SCA1、SCA2、MJD/SCA3、SCA6、SCA7、SCA17 和 DRPLA 中同源基因的蛋白同源性、表达模式和分子功能。除了 ATXN1L,我们还强调了 ATXN2L、ATXN3L、CACNA1B、ATXN7L1、ATXN7L2、TBPL2 和 RERE 作为有希望的功能候选物,它们可能在各自的 SCA 神经病理学中发挥作用,以及亲本基因。尽管这些重复物大多数缺乏(CAG/CAA)区域,但如果具有功能冗余性,它们可能会补偿野生型基因在 SCA 中的部分功能丧失或功能障碍。我们旨在提请人们注意这样一种假说,即疾病相关基因的同源基因可能是显性共济失调复杂神经病理学的基础,并促进新的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/464f/10676324/fd560d4c35a1/439_2023_2607_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验